Acting for VC investor into BioTech venture, Inoviv

We acted for a new seed-stage UK VC fund on its investment into Inoviv, a BioTech company developing bespoke biomarker tests to identify patients and demonstrate treatment efficacy for novel therapies.

Inoviv claims its tests: “support pharmaceutical companies in running successful clinical trials and in maximising access to marketed therapies”.

Deal/project: Seed investment